Q4 2020 13F Holders as of 12/31/2020
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
29.1M
-
Number of holders
-
103
-
Total 13F shares, excl. options
-
12.7M
-
Shares change
-
-731K
-
Total reported value, excl. options
-
$760M
-
Value change
-
-$25.5M
-
Put/Call ratio
-
0
-
Number of buys
-
50
-
Number of sells
-
-40
-
Price
-
$60.00
Significant Holders of Krystal Biotech, Inc. - COMMON STOCK (KRYS) as of Q4 2020
117 filings reported holding KRYS - Krystal Biotech, Inc. - COMMON STOCK as of Q4 2020.
Krystal Biotech, Inc. - COMMON STOCK (KRYS) has 103 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12.7M shares
of 29.1M outstanding shares and own 43.55% of the company stock.
Largest 10 shareholders include Redmile Group, LLC (1.68M shares), BlackRock Inc. (1.41M shares), FMR LLC (1.25M shares), FRAZIER MANAGEMENT LLC (895K shares), VANGUARD GROUP INC (739K shares), BAKER BROS. ADVISORS LP (699K shares), STATE STREET CORP (560K shares), FARALLON CAPITAL MANAGEMENT LLC (525K shares), Point72 Asset Management, L.P. (500K shares), and First Light Asset Management, LLC (492K shares).
This table shows the top 103 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.